Skip Navigation

FDA approves new version of diabetes drug Mounjaro for weight loss

apnews.com FDA approves new version of diabetes drug Mounjaro for weight loss

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug.

A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.

The U.S. Food and Drug Administration approved Eli Lilly's drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.

37
37 comments
You've viewed 37 comments.